Main container

Confronto tra radiomica e i criteri convenzionali di risposta nella previsione della progressione del tumore desmoide dopo crioablazione

Title
Confronto tra radiomica e i criteri convenzionali di risposta nella previsione della progressione del tumore desmoide dopo crioablazione
Code
CRYOMICS
Type
Osservazionale
Start Year
2023
Status
In Corso

Principal Investigator

Operational unit that carry out the study

You might also be interested in

Clinical Trial
A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors
Read more
Clinical Trial
Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors
Read more